compound 16 [PMID: 31525966]   Click here for help

GtoPdb Ligand ID: 10501

Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 16 inhibits the cytolytic pore-forming activity of the perforin 1 protein [2]. It has been developed to ascertain whether perforin inhibition can prevent early rejection of mismatched grafts in donor stem cell transplant procedures, and thereby improve successful engraftment. The acting hypothesis is based on the recognition that the natural killer (NK) cells that drive graft rejection overwhelmingly use perforin to kill non-self targets [1,3]. In addition, as these NK cells are resistant to radio- and immuno-suppression, an alternative mechanism is needed to limit their activity and to achieve clinical efficacy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 138.11
Molecular weight 528.07
XLogP 3.07
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc(s1)c1cnc2c(c1)CN(C2=O)C
Isomeric SMILES COc1ncc(cc1NS(=O)(=O)c1ccc(cc1F)F)c1ccc(s1)c1cnc2c(c1)CN(C2=O)C
InChI InChI=1S/C24H18F2N4O4S2/c1-30-12-15-7-13(10-27-22(15)24(30)31)19-4-5-20(35-19)14-8-18(23(34-2)28-11-14)29-36(32,33)21-6-3-16(25)9-17(21)26/h3-11,29H,12H2,1-2H3
InChI Key ZYYGNLSPUWSHQW-UHFFFAOYSA-N
Bioactivity Comments
Compound 16 has favourable physicochemical and pharmacokinetics profiles [2]. In vivo, compound 16's perforin-inhibiting action prevents cytotoxic T cell/natural killer cell-mediated killing of transplanted bone marrow stem cells.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
perforin 1 Hs Inhibitor Inhibition 5.3 pIC50 - 2
pIC50 5.3 (IC50 4.43x10-6 M) [2]
Description: Inhibition of perforin-mediated lysis of 51Cr-loaded K562 target cells in the presence of KHYG1 human NK cells. Measured as release of 51Cr.